Search Results Search Sort by RelevanceMost Recent Health Law Feb 2020 Can International Patent Law Help Mitigate Cancer Inequity in LMICs? Srividya Ragavan, SJD and Amaka Vanni, PhD Inequity makes it imperative to consider how trade and patent policies influence international patients’ access to treatment and prevention. AMA J Ethics. 2020;22(2):E102-111. doi: 10.1001/amajethics.2020.102. Health Law Dec 2006 Intellectual Property and Access to Medicine for the Poor Tara Leevy, LLB, LLM Intellectual property laws promulgated by the World Trade Organization affect developing nations' access to life-saving medications. Virtual Mentor. 2006;8(12):834-838. doi: 10.1001/virtualmentor.2006.8.12.hlaw1-0612. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Health Law Feb 2020 Can International Patent Law Help Mitigate Cancer Inequity in LMICs? Srividya Ragavan, SJD and Amaka Vanni, PhD Inequity makes it imperative to consider how trade and patent policies influence international patients’ access to treatment and prevention. AMA J Ethics. 2020;22(2):E102-111. doi: 10.1001/amajethics.2020.102.
Health Law Dec 2006 Intellectual Property and Access to Medicine for the Poor Tara Leevy, LLB, LLM Intellectual property laws promulgated by the World Trade Organization affect developing nations' access to life-saving medications. Virtual Mentor. 2006;8(12):834-838. doi: 10.1001/virtualmentor.2006.8.12.hlaw1-0612.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.